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Mouse modelsHyperactivation of the epidermal growth factor receptor (EGFR) in gastric cells due to excess of its ligand
transforming growth factor-α (TGFA) is associated with hyperplastic lesions in Ménétrier's disease patients
and in transgenic mice. Other EGFR ligands, however, have never been associated with stomach diseases.
Here, we report that overexpression of the EGFR ligand betacellulin (BTC) results in a severe, age-
dependent hyperplasia of foveolar epithelium. The stomach weight of affected mice reached up to 3 g rep-
resenting more than 10% of total body weight. The preexisting corpus mucosa was severely depleted, and
both parietal and chief cells were replaced by proliferating foveolar epithelium. The lesions were more severe
in male as compared to female transgenic mice, and partially regressed in the former after castration-
mediated androgen removal. The gastric hyperplasia fully disappeared when BTC-tg mice were crossed
into the EgfrWa5 background expressing a dominant-negative EGFR, indicating that the phenotype is EGFR-
dependent. This is, to our knowledge, the ﬁrst report of hyperplastic gastric lesions due to the overexpression
of an EGFR ligand other than TGFA. BTC-tg mice are therefore a new, promising model for studying EGFR-
dependent gastric polyps.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Ménétrier's disease (MD), ﬁrst described in 1888 [1], is a rare,
potentially premalignant gastric hyperproliferative disorder [2]. Clini-
cal symptoms of affected patients include abdominal pain, vomiting,
hypochlorhydria, and hypoalbuminemia. The central histological fea-
ture is a hypertrophy of the gastric mucosa with giant rugal folds,
atrophy of the body glandular compartment, marked expansion of
surface mucous cells (foveolar hyperplasia) and cystic dilation of the
gastric glands [3–7]. Increased expression of transforming growth
factor-alpha (TGFA) could be detected in patients with MD [8], and
structural and functional lesions of the stomach (including foveolar hy-
perplasia and glandular cystic dilation, decreased acid production, and
reduced number of parietal cells) were described in transgenic mice
overexpressing TGFA in this organ [8,9]. In addition, patients suffering
from MD can be successfully treated with the monoclonal antibody
Cetuximab® directed against the EGFR [2,10]. Therefore, hyper-
activation of the epidermal growth factor receptor (EGFR, ERBB1) by
local overproduction of its ligand TGFA is largely accepted as the
main pathogenic mechanism contributing to MD.al Breeding and Biotechnology,
unich, Germany. Tel.: +49 89
R. Schneider).
rights reserved.However, there are still many open questions regarding the cause
and the treatment of MD [2]. Most importantly, it is unclear whether
other EGFR ligands contribute to the disorder. TGFA is not the only li-
gand of the EGFR but is a member of a family of seven peptide growth
factors that bind and activate the EGFR in mammals [11,12]. Although
the possibility that overproduction of other EGFR ligands may result
in similar alterations of the gastric mucosa has often been discussed
during the last years [2,8], such effect has not been shown for other
ligands than TGFA so far. This is remarkable considering the high de-
gree of functional redundancy [13] and cross-induction [14] observed
in this family of ligands, and the fact that at least six EGFR ligands are
expressed at considerably high levels in the stomach [13]. In addition,
to our knowledge, no similar gastric lesions have been described in
transgenic mice overexpressing any other EGFR ligand. Whether
this relates to the expression characteristics of the model (level and
speciﬁc cell population producing the growth factor), or to intrinsic
properties of the speciﬁc growth factor remains unknown.
Among the EGFR ligands, betacellulin (BTC) is unique in its ability
to bind and activate the related ERBB4 receptor [11] and the het-
erodimeric combination ERBB2/ERBB3 [15]. Since BTC has this broad
receptor binding potential and also is widely expressed in the gastro-
intestinal tract [13], we hypothesized that this ligand would be ap-
propriate to study possible effects of EGFR ligands other than TGFA
in the stomach. In this study, we report a severe, age-dependent
hyperplasia of the gastric mucosa in transgenic mouse lines over-
expressing BTC and situate the lesions in relationship to human
diseases.
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2.1. Animals
Transgenic mice with ubiquitous overexpression of betacellulin
were generated by pronuclear microinjection of a construct in which
the mouse Btc cDNA is placed under the control of the cytomegalovirus
enhancer/chicken beta actin promoter [16]. As described previously,
some BTC-tg mice die during the ﬁrst weeks of postnatal life due to a
pulmonary pathology [16]. However, mice surviving this critical
stage grow normally and usually do not present abnormalities before
the age of 12 months. Hemizygous males from lines L2 and L4 in the
FVB/N background were mated to non-transgenic females of the
same strain and transgenic offspring were identiﬁed by PCR analysis
of tail DNA as described previously [16]. EgfrWa5 mice [17] expressing
an antimorphic EGFR were donated by the Medical Research Council
(Oxfordshire, UK) andmaintained in the C57BL/6N background. Castra-
tion of males was carried out following standard surgical procedures.
Animals were maintained under speciﬁc pathogen-free conditions in aFig. 1. Betacellulin overexpression is associated with severe hyperplastic changes of the gla
males (A) and females (B). Animals from lines L2 and L4 are included in the graphs. (C) E
ages 10–12 months (n=7–12 mice/group). (D) Gross analysis of the stomach from a contro
of the transgenic mucosa in the sagittal section (bottom picture). Evaluation of body weight
from 2 to 12 months of age (n=5–10 mice/group and time point). Northern blot (G) show
stomach. The levels of transgene-derived Btc mRNA were considerably higher than the leve
ization of BTC-positive cells (green) in the cardiac region of the stomach from control and B
out by omitting the ﬁrst antibody resulted in no staining (not shown); scale bars representclosed barrier system and had free access to a standard rodent diet
(V1534; Ssniff, Germany) and water. All experiments were approved
by the local veterinary authority and were carried out according to the
German Animal Welfare Act.
2.2. Evaluation of gastric pH
For intragastric pH measurement, 12–16 h fasted animals were
killed by cervical dislocation. The stomach was incised with precision
scissors and the gastric content was collected using a laboratory pi-
pette and the intragastric pH was measured using pH paper stripes
(Macherey-Nagel, Germany).
2.3. Histology, immunoﬂuorescence, and immunohistochemistry
During autopsy, the opened stomach was rapidly excised, ﬂushed
with ice-cold PBS, ﬁxed in 4% paraformaldehyde (in PBS) and processed
for standard histological examinations. For the visualization of prolifer-
ating cells, mice were injected i.p. with BrdU (30 mg/kg body weight;ndular stomach epithelium. Age-dependent increase in the stomach weight in BTC-tg
valuation of the relative stomach weight of BTC-tg mice and control littermates at the
l and a BTC transgenic mouse (littermates, 10 months old). Note the marked thickening
of BTC-tg males (E) and females (F) as compared to gender-matched control littermates
ing high levels of transgene-derived BTC transcripts in the forestomach and glandular
ls of endogenous Btc message (arrow, ~3 kb). Immunoﬂuorescence showing the local-
TC-tg mice (H). F-actin is detected in red by using phalloidin. Negative controls carried
100 μm. *Pb0.05; **Pb0.01; ***Pb0.001.
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was performed on 5 μm sections which were dewaxed in xylene and
rehydrated in graded alcohol. After an antigen retrieval step (0.1 M cit-
rate buffer, pH 6.0) by microwave oven for 20 min, all sections were
blocked in 1% H2O2 in methanol for 15 min. Slides were incubated
with the primary or secondary antibody for 1 h and with the avidin–
biotin complex (ABC) for 30 min. All incubation steps were performed
at room temperature. 3,3′-diaminobenzidine was used as the chromo-
gen and the nuclei were counterstained with Mayer's hematoxylin
and coverslipped using coverquick mounting medium (Labornord,
Germany). The primary antibody for detecting BrdU (rat anti-BrdU)
and the corresponding secondary antibody (rabbit anti-rat) were ob-
tained fromAbD Serotec (Germany). Negative controls (without prima-
ry antibody) were included to check for non-speciﬁc staining. For
localization of BTC and EGFR, the tissuewas frozen in OCT and sectioned
(10 μm) using a cryostat. Sections were ﬁxed in 4% paraformaldehyde
for 15 min, followed by blocking in 5% donkey serum. After blocking,
the sections were incubated for 2 h with 1/100-diluted primaryFig. 2. EGFR localization by immunoﬂuorescence (green). No differences in the EGFR expres
by using phalloidin. Negative controls carried out by omitting the ﬁrst antibody resulted inantibodies (anti-BTC, goat; anti-EGFR, goat, both from R&D Systems,
Germany) and then for 1 h with corresponding ﬂuorescence-labeled
donkey anti-goat secondary antibodies (Alexa488, Jackson Immuno-
Research Laboratories, USA) diluted 1/800. Phalloidin (Life Technolo-
gies, Germany) was employed for detecting F-actin ﬁlaments. Images
were captured with a Leica DFC425C Digital Camera and Leica Applica-
tion Suite V3.8 software (Leica Microsystems, Germany) and then
merged using Adobe Photoshop.
Muc5AC was detected using the 45M1 monoclonal antibody,
whose speciﬁcity on mouse tissues has been described previously
[18]. Antigen retrieval was performed on dewaxed and hydrated tis-
sue sections using Rodent decloaker (Biocare Medical) at 80 °C for
2 h. Sections were then treated with 3% (v/v) hydrogen peroxide,
washed, and blocked by rodent block M (Biocare Medical) for
30 min. The primary antibody (45 M1) was diluted in Antibody Dilu-
ent (1:1000) and incubated for 1 h. After washing the sections four
times in PBS containing 0.05% Tween 20, they were incubated with
MM HRP-Polymer (Biocare Medical) for 20 min. Bound antibodysion pattern between control and BTC-tg mice were observed. F-actin is detected in red
no staining (not shown). Scale bars represent 100 μm.
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terstained with Harris's hematoxylin.2.4. Northern blot
RNA isolation, blotting and Btc and Gapdh probe hybridization
were performed as described previously [16].2.5. Statistical analysis
Data are presented as means±SD. Groups were compared using
two-tailed Student t-tests (Prism 4, GraphPad Software, CA) and
Pb0.05 was considered signiﬁcant.3. Results
3.1. Increased BTC levels result in a severe hyperplasia of the gastric
epithelium
Since overexpression of TGFA is known to cause a gastric pathology
resembling Ménétrier's disease, we systematically evaluated the stom-
ach in BTC-tg animals at different ages. Necropsy of BTC-tg mice
and gender-matched control littermates revealed a dramatic, age-
dependent increase in the size and weight of the stomach in transgenic
animals. The increase in stomach weight became signiﬁcant at the age
of 4 months in transgenic males (298±28 mg vs. 194±35mg in con-
trol males; Pb0.001, n=9 and 8 animals, respectively) and females
(343±29 mg vs. 163±9 mg in control females; Pb0.001, n=5 ani-
mals/group). The stomach weight increased further in both males
(Fig. 1A) and females (Fig. 1B), reaching weights close to 3 g in males
at the age of 10–12 months. The relative stomach weight (expressed
as % of body weight) was signiﬁcantly increased in transgenic males
as compared to transgenic females, indicating amore severe phenotype
in the former gender (Fig. 1C). Gross morphologic analysis revealed an
extremely thickenedmucosa,with large nodular projectionswhich par-
tially ﬁlled the lumen, while the forestomach maintained its normal
structure (Fig. 1D). Surprisingly, these changes did not result in an ob-
servable reduction in the body weight of transgenic males (Fig. 1E) or
females (Fig. 1F) over the evaluated period.
The phenotype was observed in two independent transgenic mouse
lines (L2 and L4), indicating that the phenotype is a true consequence of
increased BTC levels rather than related to a speciﬁc transgene insertion
site. For further analysis, BTC-tg males from L2 and their non-
transgenic, gender-matched littermates were employed.Fig. 3. Time course of lesion development at the gastric cardia of BTC-tg mice. H&E
staining as well as BrdU immunohistochemistry for transgenic and control littermates
at the age of 4 weeks (A), 5 months (B) and 1 year (C) are shown.3.2. The restriction of BTC expression to the neck region is lost in BTC-tg
mice
Northern blot analysis of gastric tissue demonstrated expression
of transgene-derived Btc transcripts (~1 kb) both in the forestomach
and in the glandular stomach (Fig. 1G), indicating that these regions
respond differently to increased Btc levels. Immunoﬂuorescence rev-
ealed that BTC was detected almost exclusively in the neck region
on putative parietal cells of the cardiac region in control mice
(Fig. 1H). In contrast, BTC was detected throughout the gastric muco-
sa in BTC-tg animals (Fig. 1H), suggesting that the lesions are due not
only to increased BTC levels but possibly also caused by expression of
BTC in cells that normally lack this growth factor. In addition, immu-
noﬂuorescence revealed EGFR expression in all layers of the gastric
mucosa in the cardiac and pyloric regions of 5-month-old and 1-
year-old control mice, with no changes in the staining pattern in
BTC-tg mice (Fig. 2).3.3. The lesions are initially observed at the gastric cardia
To gain insight into the development of the disease, we assessed
the morphological changes in BTC-tg and control mice at different
ages. For each time point, at least three mice per group were histolog-
ically evaluated. At the age of 4 weeks, no obvious lesions were
detected in the stomach of transgenic mice (data not shown). Howev-
er, BrdU staining revealed that cell proliferation, which occurs mainly
in the isthmus of gastric glands between the pit and the base of the
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cardia of 4-week-old transgenic mice: proliferating cells were in-
creased in number and located towards the base of the pits
(Fig. 3A). At the age of 2 months, the lesions evolved to hyperplastic
surface epithelium (~3 mm) with foveolar cysts in subcardial locali-
zation, while the pyloric mucosa was not affected (data not shown).
Mild inﬂammation, characterized by an increased number of lympho-
cytes and plasma cells (neutrophilic granulocytes were observed only
sparsely) within the lamina propria, was also present (data not
shown). At the age of 5 months, the lesions increased in size
(~5 mm) and were characterized by polyps of nodular regenerative
epithelium with numerous foveolar cysts (Fig. 3B). Cell proliferation
was vigorous and disorganized (Fig. 3B). At the age of 8 months,
polyps were even larger (~12 mm) and at the age of 12 months, the
lesions reached a size of 15 mm and partially occluded the gastric
lumen (Fig. 1D). At 12 months of age, foveolar cysts were increasedFig. 4. The gastric lesions of 8-month-old BTC-tg mice are characterized by depletion of parie
parietal and chief cells and their replacement with mucin-secreting columnar epithelium. B:
is found throughout the stomach glandular mucosa in BTC-tg mice. C: The gastric pH is sign
littermates (n=5–8 animals/group). ***Pb0.001.in size and number, with an increase in the number of neutrophilic
granulocytes, small lymphocyte aggregations and areas of calciﬁca-
tion; BrdU-positive cells were distributed all over the hyperplastic
mass (Fig. 3C). Progression to adenocarcinomas was never observed
in hyperproliferative gastric lesions of transgenic mice.
3.4. The lesions are characterized by depletion of parietal and chief cells
and foveolar hyperplasia
Detailed histological analysis of H&E- and PAS-stained lesions at
the age of 8 months showed that these were characterized by deple-
tion of the preexisting corpus mucosa and replacement of parietal
and chief cells by proliferating foveolar epithelium with numerous
large cystic formations (Fig. 4A). MUC5AC staining conﬁrmed abun-
dant presence of mucins towards the base of the glandular mucosa,
further supporting the classiﬁcation of the lesions as foveolartal and chief cells and foveolar hyperplasia. A: H&E and PAS staining revealed the loss of
Expression of MUC5AC, restricted to the luminal region of the stomach in control mice,
iﬁcantly increased in transgenic animals of both genders as compared to their control
Fig. 6. The gastric polyps of BTC-tg mice are EGFR-dependent. H&E and PAS staining
showed that the depletion of parietal cells and the foveolar hyperplasia observed in
BTC-tg animals are completely rescued after the introduction of the antimorphic allele
Wa5. All animals are 8-month-old littermates.
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pH in 8–10 months old transgenic animals was close to neutral and
in some cases even slightly basic (Fig. 4C).
3.5. Androgen removal reduces the severity of hyperplastic lesions
To clarify whether the lack of androgens was a determinant factor
for the less pronounced stomach weight increase in transgenic fe-
males as compared to males, a cohort of transgenic males and their
non-transgenic gender-matched littermates was castrated at the age
of 4 weeks and sacriﬁced at the age of 8 months. The stomach weight
of castrated males was still signiﬁcantly higher as compared to cas-
trated control males, but signiﬁcantly reduced as compared to the
stomach weight of non-castrated BTC transgenic males of the same
age (Fig. 5A). Achlorhydria was still present, further demonstrating
that androgens inﬂuence only the degree of hyperplasia (Fig. 5B). His-
tological evaluation revealed no qualitative differences between the
lesions in castrated or non-castrated transgenic males or females
(data not shown).
3.6. The hyperplastic lesions are EGFR-dependent
To evaluate to which extent the EGFR or ERBB4 pathways are in-
volved in the development of the hyperplastic lesions in BTC-tg
mice, we crossed BTC-tg mice with EgfrWa5 mice. EgfrWa5 mice origi-
nate from an ENUmutagenesis screen, and are characterized by a mu-
tation in the tyrosine kinase domain of the EGFR, resulting in a
dominant negative receptor [17]. Since the two mouse strains were
maintained in different inbred backgrounds (see Material and
methods), their hybrid progeny is genetically uniform. While BTC-tg
mice single mutants developed the same lesions previously de-
scribed, evaluation of the stomach weight at different ages (data not
shown) and histological evaluation of the organ at the age of
8 months failed to reveal any alterations in BTC-tg/EgfrWa5 double
mutant mice (Fig. 6). Therefore, these ﬁndings strongly indicate that
the gastric hyperplastic lesions induced by BTC are fully dependent
of intact EGFR signaling.
4. Discussion
Here, we report that transgenic mice overexpressing the EGFR li-
gand BTC exhibit a remarkable, age-dependent hyperplasia of the
gastric epithelium. The lesions were characterized by hyperplasia of
foveolar epithelium with large cystic formations and depletion of
the preexisting body of the mucosa. The lesions were more severe
in transgenic males as compared to females, and partially regressed
in the former after castration-mediated androgen removal, indicatingFig. 5. Removal of the testes reduces the extent of the gastropathy. (A) 8-month-old transgenic
as compared to non-castrated transgenicmice (n=12) at the same age. Note that the stomach
(n=8) or castrated (n=5) control males. (B) The gastric pH is signiﬁcantly increased in casta partial dependence of the phenotype on androgens. Another impor-
tant aspect of the gastric lesions was the marked inﬁltration with in-
ﬂammatory cells. Gastric inﬂammation is regularly observed during
infection with Helicobacter pylori in humans, which can lead to themales castrated at the age of 3 weeks (n=5) show a signiﬁcantly lower stomach weight
weight of castrated transgenicmice is still signiﬁcantly higher as compared non-castrated
rated transgenic males as compared to their castrated control littermates. ***Pb0.001.
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Ménétrier's disease have been linked to H. pylori infection, and the
chronic inﬂammatory process in the stomach is considered to be nec-
essary for the development of gastric tumors [19]. However, involve-
ment of H. pylori in the gastric phenotype of BTC-tg mice can be
excluded since the bacterium was never detected by serological or
microbiological tests (data not shown).
Similar lesions, although considerably less dramatic, have been de-
scribed in transgenic mice overexpressing TGFA, an accepted model for
MD [8,9,20–23]. Additional features resembling TGFA transgenic mice
include an increase in the gastric pH (as a consequence of parietal
cell depletion) and a clear involvement of the EGFR.
However, would it be justiﬁable to classify the lesions observed in
the stomach of BTC-tg mice as a murine counterpart of human MD?
The histological appearance of the lesions and the involvement
of the EGFR seem to support this interpretation. However, an
upregulation of BTC has never been reported in MD patients and is
rather unlikely to play a pathogenic role in this disease. In addition,
it is important to note that the diagnosis of MD is only possible by
the combination of clinical ﬁndings and histology, and there is a
high degree of overlap in the histologic appearance of MD with
other forms of gastric polyps such as hamartomas and hyperplastic
polyps (HP). Hamartomas are polypoid lesions characterized by an
overgrowth of cells native to the area in which they normally occur
and are most commonly found in association with genetically well-
deﬁned hereditary syndromes [24]. HP are the most common form
of gastric polyps, accounting for ~70% of all polyps found after stom-
ach endoscopy [25]. Histologically, HP are characterized by promi-
nent foveolar hyperplasia, tortuosity, and stromal edema and
inﬂammation [26,27]. While the exact pathogenesis of HP remains
unknown, they are believed to be the result of regenerative phenom-
ena [26], and an involvement of the EGFR has never been reported.
Therefore, considering the lack of a perfect match to a human disease,
we deem a more broad classiﬁcation of the gastric lesions of BTC-tg
mice as EGFR-dependent gastric polyps as appropriate.
In conclusion, our study is the ﬁrst to reveal an association be-
tween gastric hyperplastic lesions and overabundance of an EGFR
ligand other than TGFA. Our ﬁndings are of special relevance consid-
ering the current interest in treating EGFR-mediated diseases with
blocking monoclonal antibodies, tyrosine kinase inhibitors, and inhib-
itors of EGFR ligand proteolytic enzymes [2]. We believe that this
mouse model may provide a valuable tool for investigating the efﬁca-
cy of novel therapeutics targeting the EGFR signaling pathway in gas-
tric diseases.
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